Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi to sell 51% stake in Opella
Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale
Sanofi entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that values the business as a whole at $17.4 billion, including debt.
Sanofi, CD&R in Exclusive Negotiations for Sale, Purchase of 50% Stake in Opella
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More.
Sanofi Enters Exclusive Talks With CD&R for Opella Sale
PARIS (Reuters) - Sanofi said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R).
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI
France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro newspaper that U.S. private equity firm Clayton Dubilier & Rice (CD&R) is to take a 51% stake in the company that makes of one of France's most-sold painkillers,
9h
on MSN
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources
Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private ...
31m
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...
12h
CD&R Nears Sanofi OTC Deal After Signing With Government
Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...
STAT
4d
Pharmalittle: We’re reading about using Lilly obesity drug to reduce sick days, Sanofi workers striking, and more
The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...
FierceBiotech
3d
Sanofi returns to Orano with €300M for radioligand 'pioneer' project
Weeks after penning a $110 million upfront deal with Orano Med for the global rights to a neuroendocrine tumor treatment, ...
2d
Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend
Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...
2d
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...
1d
Zacks Research Issues Negative Outlook for Sanofi Earnings
Analysts at Zacks Research decreased their Q4 2025 earnings estimates for Sanofi in a research note issued on Tuesday, ...
9h
French state takes stake in Sanofi unit to smooth €15.5bn US deal
Deal for consumer health arm has faced a political backlash over ceding controlling stake to American private equity group ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Opella
Doliprane
United States
PAI
France
Feedback